- Presentations
- 4
- Markets
- 1
Orencia is a brand of Abatacept marketed by ER Squibb & Sons, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Abatacept
- Brand owner
- ER Squibb & Sons
- Registered in
- United States
- Strengths and forms
- 125 mg/1 mL injection, 50 mg/0.4 mL injection, 87.5 mg/0.7 mL injection, 250 mg/15 mL powder for injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Orencia 125 mg/1 mL injectionSubcutaneous Cold chain | ER Squibb & Sons | US FDA | Available on request |
| Orencia 50 mg/0.4 mL injectionSubcutaneous Cold chain | ER Squibb & Sons | US FDA | Available on request |
| Orencia 87.5 mg/0.7 mL injectionSubcutaneous Cold chain | ER Squibb & Sons | US FDA | Available on request |
| Orencia 250 mg/15 mL powder for injectionIntravenous Cold chain | ER Squibb & Sons | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Orencia
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.